226 related articles for article (PubMed ID: 22412233)
1. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin-related amyloidoses and the heart: a clinical overview.
Rapezzi C; Quarta CC; Riva L; Longhi S; Gallelli I; Lorenzini M; Ciliberti P; Biagini E; Salvi F; Branzi A
Nat Rev Cardiol; 2010 Jul; 7(7):398-408. PubMed ID: 20479782
[TBL] [Abstract][Full Text] [Related]
3. Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Christoph DC; Boese D; Johnson KT; Schlosser TW; Hunold P; Baba HA; Erbel R; Philipp S
Circ Heart Fail; 2009 Sep; 2(5):512-5. PubMed ID: 19808383
[No Abstract] [Full Text] [Related]
4. Cardiac amyloidosis: a practical approach to diagnosis and management.
Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Ueda M; Horibata Y; Shono M; Misumi Y; Oshima T; Su Y; Tasaki M; Shinriki S; Kawahara S; Jono H; Obayashi K; Ogawa H; Ando Y
Mod Pathol; 2011 Dec; 24(12):1533-44. PubMed ID: 21822203
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Amyloidosis Phenotype Associated With a Glu89Lys Transthyretin Mutation.
Bourque PR; McCurdy AR; Mielniczuk LM; Dennie C; Veinot JP; Warman Chardon J
Can J Cardiol; 2017 Jun; 33(6):830.e5-830.e7. PubMed ID: 28395866
[TBL] [Abstract][Full Text] [Related]
7. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
[TBL] [Abstract][Full Text] [Related]
8. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
9. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man.
Marrero Negrín N; Medina Gil JM; García Cruz ML; Jiménez Cabrera F
Rev Esp Cardiol (Engl Ed); 2019 Dec; 72(12):1086-1088. PubMed ID: 31561982
[No Abstract] [Full Text] [Related]
11. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
12. [Familial approach in hereditary transthyretin cardiac amyloidosis].
García-Pavía P; Avellana P; Bornstein B; Heine-Suñer D; Cobo-Marcos M; Gómez-Bueno M; Segovia J; Alonso-Pulpón LA
Rev Esp Cardiol; 2011 Jun; 64(6):523-6. PubMed ID: 21439703
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
[TBL] [Abstract][Full Text] [Related]
14. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
Jacobson D; Tagoe C; Schwartzbard A; Shah A; Koziol J; Buxbaum J
Am J Cardiol; 2011 Aug; 108(3):440-4. PubMed ID: 21600538
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
16. Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis.
Florian A; Bietenbeck M; Chatzantonis G; Hüsing-Kabar A; Schmidt H; Yilmaz A
Clin Res Cardiol; 2020 Jul; 109(7):949-956. PubMed ID: 32048001
[No Abstract] [Full Text] [Related]
17. Cardiac transthyretin amyloidosis.
Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
[TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis: heterogenous pathogenic backgrounds.
Ikeda S
Intern Med; 2004 Dec; 43(12):1107-14. PubMed ID: 15645642
[TBL] [Abstract][Full Text] [Related]
19. Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family.
Hamidi Asl K; Nakamura M; Yamashita T; Benson MD
Amyloid; 2001 Dec; 8(4):263-9. PubMed ID: 11791619
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
